One of the most common questions we hear from patients is a hopeful one: "I hit my goal, so can I stop now?" It is a fair question, and it deserves a straight answer. Deciding when to stop taking a GLP-1 is less about a number on the scale and more about protecting the progress you worked for.
When to Stop Taking a GLP-1: The Short Answer
Reaching your goal weight and being ready to stop treatment are two different milestones. Hitting your target tells us the medication is working. It does not automatically mean your body will hold that weight without support.
Here is the part patients are often not told up front. Obesity is a chronic condition, and the leading research treats it that way. Findings confirm the chronicity of obesity and suggest ongoing treatment is required to maintain improvements in weight and health.
That framing matters. We do not tell someone with high blood pressure to stop their medication the week their numbers look good. GLP-1 care often works the same way, as a long-term tool rather than a short sprint.
Why Goal Weight Is Not the Same as "Done"
To understand the finish line, it helps to know what these medications actually do. GLP-1 receptor agonists suppress appetite and enhance satiety by acting on the central nervous system, which leads to reduced caloric consumption and weight loss.
They also work in your gut. The medications reduce appetite and slow down gastric emptying, which can increase a sense of fullness and decrease hunger.
When you stop, those signals fade. Your body tends to push appetite back up, which is why stopping is a real decision and not just a formality. To understand the medications we use, see our medications overview.
The Three Options: Goal Weight, Maintenance, and Stopping
When you reach your target, we usually talk through three paths.
1. Stay at your current dose
Some patients keep going at their full dose because it feels right and their goals are still moving. There is nothing wrong with this if you and your doctor agree it fits.
2. Move to a maintenance approach
Many patients shift to a lower or less frequent dose that holds their weight steady. In our practice, patients often find a maintenance rhythm that keeps appetite manageable without pushing for more loss.
3. Taper off entirely
Some patients do choose to stop, whether by preference, cost, or a season of life. When they do, we plan the exit rather than quitting cold. Current evidence suggests that adopting an individualised dose-tapering approach can limit weight regain.
Being Honest About Regain Risk
We will not sugarcoat this, because you deserve real numbers to make a real choice. Stopping a GLP-1 often leads to some regain, and that is biology, not a personal failing.
In a large systematic review, at 1 year post-cessation, 60% of the weight lost during treatment was regained. The same analysis found the trend does not continue forever. Weight regain appears to plateau below pre-treatment levels, suggesting that partial weight-loss benefit may persist long-term but is substantially attenuated.
Real-world data is often gentler than clinical trials. In one very large analysis, at 24 months post-cessation, 56% of semaglutide, 52% of liraglutide, and 55% of tirzepatide patients kept the weight off or lost additional weight.
Why the difference? Patients in trials typically lose more weight due to longer treatment duration, so discontinuation leads to a sharper rebound. The takeaway is not fear. It is that stopping works best with a plan.
What the Conversation With Your Doctor Sounds Like
This is a shared decision, and it is a real conversation. In a visit, we usually walk through a few honest questions together.
- How steady has your weight been at this dose?
- How are your eating habits and activity holding up on their own?
- What are your health markers doing, like blood sugar and blood pressure?
- What matters more to you right now, staying on treatment or trying life without it?
We also talk about what happens if the scale moves after stopping. Restarting is not a defeat, it is a normal part of managing a chronic condition. This program is physician-led by Dr. Tran Le, MD, DABOM, triple board-certified in Obesity Medicine, Addiction Medicine, and Occupational and Environmental Medicine, so these decisions are made with genuine clinical oversight.
Curious how visits and follow-ups work? See how it works.
Building a Maintenance Plan That Lasts
Medication is one tool, not the whole toolbox. Appetite sensation and eating behavior are important factors in maintenance of weight loss.
That is why we pair any dosing plan with steady habits: protein-forward meals, strength training, sleep, and regular check-ins. These are the things that carry your results whether you are on a full dose, a maintenance dose, or taking a break.
A quick note: this article is educational and not personal medical advice. Your plan should come from a visit, not a blog post.
Frequently Asked Questions
Is there a "right" time to stop a GLP-1?
There is no universal stopping point. Because obesity is treated as a chronic condition, many patients stay on some form of therapy long term, while others taper with a plan. The right time is the one you and your doctor decide together.
Will I gain all the weight back if I stop?
Not necessarily. Some regain is common, but the amount varies widely between people. Real-world data shows many patients keep a meaningful share of their loss, especially with strong habits and a gradual taper.
Can I lower my dose instead of quitting completely?
Often, yes. A maintenance approach lets many patients hold their weight with less medication. This is a personalized decision, so bring it up at your next visit.
Ready to Talk Through Your Plan?
Whether you are approaching your goal or just starting out, you should not have to guess about the next step. Our team can help you decide between goal weight, maintenance, and a planned taper, with pricing that keeps the medication included. Compare our options on the pricing page, or start your consultation today.
Sources
- Diabetes, Obesity and Metabolism: Weight regain and cardiometabolic effects after withdrawal of semaglutide (STEP 1 extension)
- eClinicalMedicine (The Lancet): Trajectory of weight regain after cessation of GLP-1 receptor agonists
- Epic Research: Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Weight Loss
- AJMC: Weight Regain After GLP-1 Discontinuation Is Less Rapid in the Real World
- NIDDK: What's New in Medications for Weight Management
- The American Journal of Medicine: Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss
- ClinicalTrials.gov: Young Adults With Early-onset Obesity Treated With Semaglutide